Jun Zhang Download Headshot

Jun Zhang, MD

  • Houston Methodist thoracic medical oncologist
  • Assistant Professor of Clinical Medicine in Oncology, Houston Methodist Institute for Academic Medicine
  • Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Media Contact: Amy Rose , 412.613.1428

Jun Zhang, MD

Request Interview
Media Contact: Amy Rose , 412.613.1428

Areas of Expertise

  • Bladder cancer
  • Cancer immunotherapy
  • Clinical expertise
  • Head and neck cancer
  • Innovative therapy in lung, head and neck, bladder and kidney cancer
  • Kidney cancer
  • Lung cancer
  • Malignant mesothelioma
  • Research interests

Credentials

BOARD CERTIFICATION
Internal Medicine, Medical Oncology, Hematology | 1992
MEDICAL SCHOOL
Hunan Medical University, China | 1992
INTERNSHIP/RESIDENCY
Internal Medicine | Brookdale University Hospital and Medical Center, Brooklyn, New York | 2005
RESIDENCY
Internal Medicine | New Hanover Regional Medical Center. Wilmington, North Carolina
FELLOWSHIP
Medical Oncology and Hematology | Brody School of Medicine, East Carolina University, Greenville, North Carolina | 2009

Publications

Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience
Ranganathan, S, Riveros, C, Xu, S, Hu, S, Geng, M, Huang, E, Melchiode, Z, Zhang, J, Efstathiou, E, Chan, KS, Wallis, CJD, Sonpavde, G & Satkunasivam, R 2024, , Urologic Oncology: Seminars and Original Investigations, vol. 42, no. 9, pp. 291.e13-291.e25. https://doi.org/10.1016/j.urolonc.2024.04.006

Treatment at Twilight: An Analysis of Therapy Patterns and Outcomes in Adults 80 Years and Older With Advanced or Metastatic NSCLC
Burns, EA, Chen, WH, Mathur, S, Kieser, RB, Zhang, J & Bernicker, EH 2023, , JTO Clinical and Research Reports, vol. 4, no. 10, 100570. https://doi.org/10.1016/j.jtocrr.2023.100570

Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population
Kemnade, JO, Florez, M, Sabichi, A, Zhang, J, Jhaveri, P, Chen, G, Chen, A, Miller-Chism, C, Shaun, B, Hilsenbeck, SG, Hernandez, DJ, Skinner, HD & Sandulache, VC 2023, , Oral Oncology, vol. 145, 106536. https://doi.org/10.1016/j.oraloncology.2023.106536

Treatment at Twilight: An Analysis of Therapy Patterns and Outcomes in Adults 80 Years and Older With Advanced or Metastatic NSCLC
Burns, EA, Chen, WH, Mathur, S, Kieser, RB, Zhang, J & Bernicker, EH 2023, , JTO Clinical and Research Reports, vol. 4, no. 10, 100570, pp. 100570. https://doi.org/10.1016/j.jtocrr.2023.100570

Single-port transoral robotic surgery for a rare tonsil mass
Allen, DZ, Gorelik, D, Butler, EB, Zhang, J & Kain, JJ 2023, , Journal of Surgical Case Reports, vol. 2023, no. 4, rjad197. https://doi.org/10.1093/jscr/rjad197

Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy
Riveros, C, Ranganathan, S, Xu, J, Chang, C, Kaushik, D, Morgan, M, Miles, BJ, Muhammad, T, Anis, M, Aghazadeh, M, Zhang, J, Efstathiou, E, Klaassen, Z, Brooks, MA, Rini, B, Wallis, CJD & Satkunasivam, R 2023, , Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 3, pp. 150.e1-150.e9. https://doi.org/10.1016/j.urolonc.2022.11.022

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2023, , Clinical and Translational Radiation Oncology, vol. 39, 100592, pp. 100592. https://doi.org/10.1016/j.ctro.2023.100592

Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy
Riveros, C, Ranganathan, S, Xu, J, Chang, C, Kaushik, D, Morgan, M, Miles, BJ, Muhammad, T, Anis, M, Aghazadeh, M, Zhang, J, Efstathiou, E, Klaassen, Z, Brooks, MA, Rini, B, Wallis, CJD & Satkunasivam, R 2023, , Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 3, pp. 150.e1-150.e9. https://doi.org/10.1016/j.urolonc.2022.11.022

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer: Cancers
Burns, EA, Gee, K, Kieser, RB, Xu, J, Zhang, Y, Crenshaw, A, Muhsen, IN, Mylavarapu, C, Esmail, A, Shah, S, Umoru, G, Sun, K, Guerrero, C, Gong, Z, Heyne, K, Singh, M, Zhang, J, Bernicker, EH & Abdelrahim, M 2023, . Cancers. https://doi.org/10.3390/cancers15010081

1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)
Gee, K, Wiechmann, C, Burns, EA, Xu, J, Zhang, Y, Esmail, A, Crenshaw, A, Kieser, RB, Umoru, G, Muhsen, I, Sun, K, Gong, Z, Shah, S, Singh, M, Zhang, J, Bernicker, E & Abdelrahim, M 2023, , Journal for immunotherapy of cancer, vol. 11, no. Suppl 1, pp. A1361-A1361. https://doi.org/10.1136/jitc-2023-SITC2023.1234

1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
Wiechmann, C, Gee, K, Burns, EA, Xu, J, Zhang, Y, Crenshaw, A, Esmail, A, Kieser, RB, Umoru, G, Muhsen, I, Sun, K, Gong, Z, Shah, S, Singh, M, Zhang, J, Efstathiou, E & Abdelrahim, M 2023, , Journal for immunotherapy of cancer, vol. 11, no. Suppl 1, pp. A1360-A1360. https://doi.org/10.1136/jitc-2023-SITC2023.1233

A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer
Guan, J, Sun, K, Guerrero, CA, Zheng, J, Xu, Y, Mathur, S, Teh, BS, Farach, A, Zhang, J, Butler, E, Pan, PY, Zsigmond, E, Mei, Z, Mejia, J, Chen, SH, Chang, JC & Bernicker, EH 2023, , International Journal of Radiation Oncology Biology Physics, vol. 118, no. 5, pp. 1531-1540. https://doi.org/10.1016/j.ijrobp.2023.08.044

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Burns, EA, Gee, K, Kieser, RB, Xu, J, Zhang, Y, Crenshaw, A, Muhsen, IN, Mylavarapu, C, Esmail, A, Shah, S, Umoru, G, Sun, K, Guerrero, C, Gong, Z, Heyne, K, Singh, M, Zhang, J, Bernicker, EH & Abdelrahim, M 2022, , Cancers, vol. 15, no. 1. https://doi.org/10.3390/cancers15010081

Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Burns, EA, Gee, K, Kieser, RB, Xu, J, Zhang, Y, Crenshaw, A, Muhsen, IN, Mylavarapu, C, Esmail, A, Shah, S, Umoru, G, Sun, K, Guerrero, C, Gong, Z, Heyne, K, Singh, M, Zhang, J, Bernicker, EH & Abdelrahim, M 2022, , Cancers, vol. 15, no. 1, 81. https://doi.org/10.3390/cancers15010081, https://doi.org/10.3390/cancers15010081

480 Impact of infections in patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving pembrolizumab-based therapies
Burns, EA, Xu, J, Kieser, R, Muhsen, I, Shah, S, Umoru, G, Mylavarapu, C, Zhang, Y, Crenshaw, A, Sun, K, Esmail, A, Guerrero, C, Gong, Z, Gee, K, Heyne, K, Singh, M, Zhang, J, Bernicker, E & Abdelrahim, M 2022, , J Immunother Cancer, vol. 10, no. Suppl 2, pp. A501. https://doi.org/10.1136/jitc-2022-SITC2022.0480

A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: The RAD VACCINE MIBC trial
Satkunasivam, R, Lim, K, Teh, BS, Guzman, J, Zhang, J, Farach, A, Chen, SH, Wallis, CJD, Efstathiou, E, Esnaola, NF & Sonpavde, GP 2022, , Future Oncology, vol. 18, no. 25, pp. 2771-2781. https://doi.org/10.2217/fon-2022-0380

Infections and their impact on patients on pembrolizumab-based therapies for head and neck cancer. Journal of Clinical Oncology
Zhang, Y, Xu, J, Muhsen, I, Burns, EA, Shah, SM, Umoru, G, Mylavarapu, C, Sun, K, Crenshaw, A, Esmail, A, Kieser, RB, Guerrero, C, Gong, Z, Gee, K, Heyne, K, Singh, M, Zhang, J & Abdelrahim, M 2022, , Journal of Clinical Oncology, vol. 40, no. 16_suppl, pp. 6035.

Outcomes of patients with advanced urothelial cancer who develop infection while on treatment with pembrolizumab. Journal of Clinical Oncology
Kieser, RB, Xu, J, Burns, EA, Muhsen, I, Shah, SM, Umoru, G, Mylavarapu, C, Sun, K, Zhang, Y, Crenshaw, A, Esmail, A, Guerrero, C, Gong, Z, Gee, K, Heyne, K, Singh, M, Zhang, J, Efstathiou, E, Bernicker, E & Abdelrahim, M 2022, , Journal of Clinical Oncology, vol. 40, no. 16_suppl, pp. 4573. https://doi.org/10.1200/JCO.2022.40.16_suppl.4573

Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database
Celtik, K, Lim, K, Dursun, F, Xu, J, Klaassen, Z, Zhang, J, Efstathiou, E, Sonpavde, G, Wallis, C & Satkunasivam, R 2022, , Clinical Genitourinary Cancer, vol. 20, no. 3, pp. 244-251. https://doi.org/10.1016/j.clgc.2022.01.011

Time Interval to Initiation of Whole-Brain Radiation Therapy in Patients With Small Cell Lung Cancer With Brain Metastasis
Chevli, N, Hunt, A, Haque, W, Farach, AM, Messer, JA, Sukpraprut-Braaten, S, Bernicker, EH, Zhang, J, Butler, EB & Teh, BS 2021, , Advances in Radiation Oncology, vol. 6, no. 6, 100783. https://doi.org/10.1016/j.adro.2021.100783

Languages

  • English